SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 21, 2026

TAK

TAKEDA PHARMACEUTICAL CO LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $598K total
Actionable Insight • Neutral

Insider sales are trivial in size and involve non-C-suite executives, no actionable signal. Monitor for any material corporate events (e.g., pipeline readouts, regulatory decisions) that could drive the stock, but this cluster alone does not warrant a trade.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$18.24
T+0 close · Aug 21, 2026 · via day close
Latest settled
+3.89%
T+20 · $18.95 · next T+60 in 9h
Vs SPY
+2.59%
α at T+20
Latest observation
+17.80%
T+57 · FF3 residual α
  1. T+0 · Aug 24 $18.24entry
  2. T+1 · 3mo ago +0.60%α +0.28% · $18.35
  3. T+5 · 3mo ago −1.43%α −1.89% · $17.98
  4. T+20 · 8w ago +3.89%α +2.59% · $18.95
  5. T+59 · todayOpen
  6. T+60 · in 9h Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Takeda insiders, the President of R&D and the Chief Human Resources Officer, sold a combined $598K in open-market sales over two days. The total is ~0.001% of the $57.3B market cap, well below the 0.1% materiality threshold, and both sales are likely routine portfolio diversification or tax-related. No bullish or bearish signal from this cluster.

Key Financial Metrics

Direction
selling
Total Value
$598.0K
Insiders
2

Key Facts

  • President of R&D sold 19,651 shares for $363K on 2026-08-19
  • Chief Human Resources Officer sold 12,980 shares for $235K on 2026-08-18
  • Total cluster value of $598K represents ~0.001% of Takeda's $57.3B market cap
  • Both transactions are open-market sales with no insider purchases in the window

Financial Impact

Total insider sales of $598K, immaterial relative to $57.3B market cap

insider_holdings

Risk Factors

  • Insider sales could be misinterpreted as bearish by retail traders
  • No insider buying to offset the selling signal

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TAK-1787378795017

Track record

18 reports on TAK

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
  2. Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
  3. Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
  4. Oct 29, 202618d ago 6-K Neutral 4/10 No price data
  5. Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
  6. Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
  7. Aug 21, 202612w ago Insider Cluster Neutral 2/10 Viewing Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
  8. Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
  9. Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
  10. Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 22, 2026